¿¡Å½ºÎÅç¿¡ ÀÇÇÑ ±Þ¼º ½ÅÁúȯ 1¿¹
A Case of Acute Kidney Injury in a Patient with Pulmonary Tuberculosis Receiving Ethambutol Therapy

´ëÇѳ»°úÇÐȸÁö 2014³â 87±Ç 3È£ p.352 ~ p.356

ȫâ¿ì(Hong Chang-Woo) - ´ë±¸°¡Å縯´ëÇб³ Àǰú´ëÇÐ ³»°úÇб³½Ç
³ë½Å¿µ(Nho Sin-Young) - ´ë±¸°¡Å縯´ëÇб³ Àǰú´ëÇÐ ³»°úÇб³½Ç
ÀÌÀÎÈñ(Lee In-Hee) - ´ë±¸°¡Å縯´ëÇб³ Àǰú´ëÇÐ ³»°úÇб³½Ç
¾È±â¼º(Ahn Ki-Sung) - ´ë±¸°¡Å縯´ëÇб³ Àǰú´ëÇÐ ³»°úÇб³½Ç
¹Ú°ü±Ô(Park Kwan-Kyu) - ´ë±¸°¡Å縯´ëÇб³ Àǰú´ëÇÐ º´¸®Çб³½Ç
°­°Ç¿ì(Kang Gun-Woo) - ´ë±¸°¡Å縯´ëÇб³ Àǰú´ëÇÐ ³»°úÇб³½Ç

Abstract

Ç×°áÇÙÁ¦ »ç¿ë ÈÄ ¹ß»ýÇÑ ±Þ¼º ½ÅÁúȯÀº ¸®ÆÊÇÉ¿¡ ÀÇÇÑ ºÎÀÛ¿ëÀÌ ¿øÀÎÀÏ ¼ö ÀÖÀ¸³ª ¸Å¿ì µå¹°°Ô ¿¡Å½ºÎÅç¿¡ ÀÇÇØ¼­µµ À¯¹ßµÉ ¼ö ÀÖ´Ù. ÀÌ¿¡ ÀúÀÚ µîÀº °í¿ë·®ÀÇ ¿¡Å½ºÎÅç º¹¿ë°ú °ü·ÃµÈ Á÷Á¢ÀûÀÎ ¼¼Æ÷µ¶¼ºÀ¸·Î À¯¹ßµÈ ±Þ¼º »çÀÌÁúÄáÆÏ¿°¿¡ ÀÇÇÑ ±Þ¼º ½ÅÁúȯÀ¸·Î Áø´ÜÇÏ¿´°í ¿¡Å½ºÎÅç »ç¿ëÀ» ÁßÁöÇÏ°í ´ëÁõ¿ä¹ý ½ÃÇุÀ¸·Î ½Å±â´ÉÀÌ È£ÀüµÈ Áõ·Ê¸¦ °æÇèÇÏ¿´±â¿¡ ¹®Çå°íÂû°ú ÇÔ²² À̸¦ º¸°íÇÏ´Â ¹ÙÀÌ´Ù.
Ethambutol is commonly used as a first-line drug for the treatment of tuberculosis. The most serious adverse effect of ethambutol therapy is optic neuropathy. However, ethambutol-induced acute kidney injury is extremely rare. We report herein a case of acute kidney injury secondary to ethambutol-associated acute interstitial nephritis. A 65-year-old man with pulmonary tuberculosis presented with a > 7-day history of nausea and vomiting. He had begun antituberculosis medications including ethambutol 3 weeks previously. His laboratory findings showed elevated blood urea nitrogen and serum creatinine levels (32.6 and 3.6 mg/dL, respectively). Examination of percutaneous renal biopsy specimens showed diffuse interstitial mononuclear cell infiltration with mild interstitial edema. The patient was treated by cessation of ethambutol and supportive care. His renal function completely recovered (creatinine, 1.1 mg/dL) and his clinical symptoms improved.

Ű¿öµå

¿¡Å½ºÎÅç, »çÀÌÁúÄáÆÏ¿°, ±Þ¼º ½ÅÁúȯ
Ethambutol, Interstitial nephritis, Acute kidney injury
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Ű¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆÇ³âµµ(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå